OliX Pharmaceuticals Inc

226950

Company Profile

  • Business description

    OliX Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in developing RNA interference (RNAi) technology therapeutics for dermal, ophthalmic and pulmonary diseases. The company’s pipeline products include OLX101, OLX201, OLX301, OLX102, and others.

  • Contact

    No. 1014 Gwanggyo Ace Tower 1
    Daehak 4-ro, Yeongtong-gu
    Gyeonggi
    Suwon16226
    KOR

    T: +82 317798400

    http://www.olixpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    69

Stocks News & Analysis

stocks

Unconventional wisdom: Are dividends the answers?

As investors toil in complexity the obvious solution may be the right one.
stocks

Netflix: A business that’s nearly flawless

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks

Trump’s US dollar assault is fuelling CBA’s rise

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,979.4022.00-0.24%
CAC 407,818.2832.15-0.41%
DAX 4024,295.9355.110.23%
Dow JONES (US)44,693.91316.38-0.70%
FTSE 1009,138.3776.880.85%
HKSE25,667.18129.110.51%
NASDAQ21,057.9637.940.18%
Nikkei 22541,826.34655.021.59%
NZX 50 Index12,795.959.18-0.07%
S&P 5006,363.354.440.07%
S&P/ASX 2008,709.4027.80-0.32%
SSE Composite Index3,605.7323.430.65%

Market Movers